T cell vaccination: Clinical application in autoimmune diseases

Journal of Molecular Medicine

Volumn 74, Issue 11, 1996, Pages 653-662

  Zhang, J ^a,b,c   Stinissen, P ^a   Medaer, R ^a   Raus, J ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autoimmune disease; Multiple sclerosis; Myelin basic protein; T cell clone; T cell vaccination

Indexed keywords

MYELIN BASIC PROTEIN; T CELL VACCINE; UNCLASSIFIED DRUG; VACCINE;

AUTOIMMUNITY; ETIOLOGY; HUMAN; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THERAPY; VACCINATION;

AUTOIMMUNE DISEASES; HUMANS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; T-LYMPHOCYTES; VACCINATION; VACCINES;

EID: 0029825171     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050069     Document Type: Review

References (43)

1. Zhang J (1995) Multiple sclerosis: perspectives on autoimmune pathology and prospects for therapy. In: Appel S (ed) Current neurology. Mosby-Year Book, Chicago, pp 115-155
2. Zhang J, Medaer R, Stinissen P, Hafler DA, Raus J (1993) MHC restricted clonotypic depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261: 1451-1454
3. Weiner HL, Freidman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA (1994) Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12:809-837
4. Bourdette DN, Whitham RH, Chou YK, Morrison WJ, Atherton J, Kenny C, Liefeid D, Hashim GA, Offner H, Vandenbark AA (1994) Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides. J Immunol 152:2510-2519
5. Cohen IR (1989) Natural Id-Anti-Id Networks and the immunological homunculus. In: Atlan H, Cohen IR (eds) Theories of immune networks. Springer. Berlin Heidelberg New York, pp 6-12
6. Ben-Nun A, Wekerle H, Cohen IR (1981) Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 292:60-61
7. Zhang J, Weiner HL, Hafler DA (1992) Autoreactive T cells in multiple sclerosis. Intern Rev Immunol 9:183-199
8. Ben-Nun A, Cohen IR (1982) Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol 129:303-309
9. Zamvil SS, Nelson PA, Trotter J, Mitchell DJ, Knobler R, Fritz R, Steinman L (1985) T cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination Nature 317:355-358
10. Mor F, Cohen IR (1993) Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. J Clin Invest 92:2199-2206
11. Howell, MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989) Vaccination against experimental encephalomyelitis with T cell receptor peptides. Science 246:668
12. Vandenbark AA, Hashim GA, Offner H (1989) Immunization with a synthetic T cell receptor V region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541-544
13. Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinman L (1988) Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263-273
14. Zhang J, Markovic S, Lacet B, Raus J, Weiner HL, Hafler DA (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179: 973-984
15. Chou YK, Bourdette DN, Offner H, Whitham R, Wang RY, Hashim GA, Vandenbark AA (1992) Frequency of T cells specific for myelin basic protein and myelin proteolipid protein blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 38:105-114
16. Allegretta M, Nicklas JA, Sriam S, Albertini RJ (1990) T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718-721
17. Oksenberg J, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CC, Steinman L (1993) Selection for T cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68-73
18. Vandevyver C, Mertens N, van den Elsen P, Raus J, Zhang J (1995) Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 25:958-968
19. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K, Hafler DA (1994) Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 152:5581-5592
20. Zhang J., Medaer R, Hashim G, Ying C, van den Berg-Loonen E, Raus J (1992) Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 32:330-336
21. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T cell recognition of an immunodominant MBP epitope in multiple sclerosis. Nature 346:183-187
22. Pette M, Fujita K, Wilkinson D, Altmann DM. Trowsdale J, Giegerich G, Hinkkanen A, Epplen JT, Kappos L, Wekerle H (1990) Myelin autoreactivity in multiple sclerosis: recognition of MBP in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci USA 87:7968-7972
23. Martin R, Howell MD, Jaraquemada D, Richert JR, Flerlage M, Robinson E, Stone R, Riddison WE, McFarlin DE, McFarland HF (1991) A MBP peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173:19-24
24. Zhang J, Chou SHJ, Hashim GA, Medaer R, Raus J (1990) Preferential peptide and HLA restriction of MBP specific T cell clones derived from MS patients. Cell Immunol 129:189-198
25. Lider O, Reshef T, Beraud E, Ben-Nun A, Cohen IR (1988) Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 239:181-184
26. Davis MM, Bjorkman PJ (1988) T cell antigen receptor genes and T cell recognition. Nature 334:393-402
27. + cells recognizing epitopes of the T cell receptor β chain from a myelin basic protein-specific T cell clone. Eur J Immunol 23:530-540
28. Lohse AW, Mor F, Karin N, Cohen IR (1989) Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244: 820-822
29. Hafler D, Cohen IR, Benjamine D, Weiner HL (1992). T cell vaccination in multiple sclerosis: a preliminary report. Clin Immunol Immunopath 62: 307-312
30. Van Laar JM, Miltenburg AMM, Verdonk MJA, Leow A, Elferink BG, Daha MR, Cohen IR, de Vries RR, Breedveld FC (1993) Effects of treatment with attenuated, autologous T cells in patients with rheumatoid arthritis. J Autoimm 6:195-166
31. Van Laar JM, Miltenburg AMM, Verdonk MJA, Leow A, Elferink BG, Daha MR, de Vries RR, Breedveld FC (1993) Activated synovial T cell clones from a patient with rheumatoid arthritis induce proliferation of autologous peripheral blood-derived T cells. Cell Immunol 146:71-80
32. Lohse AW, Bakker NP, Hermann E, Poralla T, Jonker M, Meyer ZUM, Buschenfelde KH (1993) Induction of an anti-vaccine response by T cell vaccination in non-human primates and humans. J Autoimm 6:121-130
33. Chou YK, Morrison WJ, Weinberg AD, Dedrick R, Whitham R, Bourdette DN, Hashim GA, Offner H, Vandenbark AA.(1994) II. Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 152:2520-2529
34. Hafler D, Saadeh MG, Kuchroo VK, Milford E, Steiman L (1996) TCR usage in human and experimental demyelinating disease. Immunol Today 17:152-159
35. Lefkovits I, Waldmann H (1984) Limiting dilution analysis of the cells of immune system. I, II. The clonal basis of the immune response. Immunol Today 5:265-295
36. Segel LA, Jager E, Elias D, Cohen IR (1995) A quantitative model of autoimmune disease and T cell vaccination: does more mean less? Immunol Today 16:80-84
37. De Alboran IM, Gutierrez, JC, Gonzalo JA, Andreu JL, Marcos MA, Kroemer G, Martinez C (1992) lpr T cells vaccinate against lupus in MRL/lpr mice. Eur J Immunol 22:1089-1093
38. Zhang J, Raus J (1995) T cell vaccination trial in multiple sclerosis. In: Zhang J, Raus J (eds) Autoimmune disease and T cell vaccination. Springer, Berlin Heidelberg New York/Landes Medical, Austin, pp 135-160
39. Zhang J, Raus J (1993) T cell vaccination in human autoimmune diseases: from laboratory to clinic. Hum Immunol (editorial) 38:87-96
40. Zhang J, Vandevyver C, Stinissen P, Raus J (1995) In vivo clonotypic regulation of human myelin basic protein-reactive T cell's by T cell vaccination. J Immunol 155:5808-5877
41. Medaer R, Stinissen P, Truyen L, Raus J, Zhang J (1995) Depletion of myelin basic protein autoreactive T cells by T cell vaccination: clinical trial in multiple sclerosis. Lancet 346: 807-808
42. Poser CM, Paty DW, Scheinberg L, McDonald I, Davis F, Ebers G, Johnson K, Sibley W, Silberberg D, Tourtellotte W (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-234
43. Truyen L, Gheuens J, Van de Vyver FL, Parizel PM, Peersman GV, Martin JJ (1990) Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of extensive standardized imaging-protocol. J Neurol Sci 96:173-182